merck-sharp-dohme-llc

Documents about merck-sharp-dohme-llc

• W911QY21C0031 — MERCK SHARP & DOHME LLC — Department of Defense ($2,205,000,834)#604607USAspending
• HHSD200201458150C — MERCK SHARP & DOHME LLC — Department of Health and Human Services ($1,480,605,084)#604812USAspending
• HHSD200201793273C — MERCK SHARP & DOHME LLC — Department of Health and Human Services ($1,453,663,190)#604824USAspending
• HHSD200201354509C — MERCK SHARP & DOHME LLC — Department of Health and Human Services ($1,372,607,194)#604861USAspending
• Sugammadex Hypersensitivity Study (Study P06042)#18715ClinicalTrials.gov
• Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED)#862941ClinicalTrials.gov
• MK0767 and Metformin Combination Study (0767-028)#121301ClinicalTrials.gov
• Study A - MK0767 Monotherapy Study#451437ClinicalTrials.gov
• Post Marketing Surveillance Study of Cuprimine#1113339ClinicalTrials.gov
• Remicade Safety Line (Study P03236)(COMPLETED)#1138757ClinicalTrials.gov
• Stocrin Re-examination Study (0831-028)#1337592ClinicalTrials.gov
• The OBSTACLE Hypoglycemia Study (MK-0000-158)#67777ClinicalTrials.gov
• ZOSTAVAX(R) Local Registration Trial (V211-019)#230478ClinicalTrials.gov
• ALPHA Sitagliptin Add on to Metformin (0431-103)#349919ClinicalTrials.gov
• Rotavirus Efficacy and Safety Trial (REST)(V260-006)#674787ClinicalTrials.gov
• MK0524A Clinical Efficacy Study (0524A-026)(COMPLETED)#828279ClinicalTrials.gov
• Safety and Tolerability of Odanacatib (0822-059)#918010ClinicalTrials.gov
• Re-examination Study For Varivax (V210-059 AM2)#1010371ClinicalTrials.gov
• GARDASIL Reexamination Study (V501-059)#1096244ClinicalTrials.gov
• MSD Belzutifan PAS#1162162ClinicalTrials.gov
• Sitagliptin/Metformin Fed Bioequivalence Study (0431A-080)#238310ClinicalTrials.gov
• Initial Combination With Pioglitazone Study (0431-064)#407827ClinicalTrials.gov
• V260 Registration Study (V260-013)(COMPLETED)#856491ClinicalTrials.gov
• ROTATEQ™ Post-Marketing Surveillance in the Philippines#1072020ClinicalTrials.gov
• A Study in Subjects With Retinal Detachment#1139934ClinicalTrials.gov
• MK3207 for Treatment of Acute Migraines (3207-005)#1321353ClinicalTrials.gov
• Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001)#18697ClinicalTrials.gov
• Sitagliptin Added-on to Insulin Study (0431-051)#28584ClinicalTrials.gov
• Bioequivalence Study of Sitagliptin/Metformin Combination Tablet (MK0431A-122)#121320ClinicalTrials.gov
• Dose-Range Finding Study for MK0893 (0893-008)#148699ClinicalTrials.gov
• ZOSTAVAX™ in Patients on Chronic/Maintenance Corticosteroids (V211-017) (COMPLETED)#279581ClinicalTrials.gov
• ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034)#332801ClinicalTrials.gov
• Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182)#349938ClinicalTrials.gov
• A Measles, Mumps, and Rubella Investigational Vaccine Trial (V205C-010)(COMPLETED)#387201ClinicalTrials.gov
• Pharmacokinetic (PK) Characterization of Subcutaneous Tulisokibart (MK-7240-010)#830434ClinicalTrials.gov
• Hepatitis B Vaccine Booster Study (V232-058)(COMPLETED)#868084ClinicalTrials.gov
• Comparative Study of Rocuronium With Vecuronium (Study 71101)(COMPLETED)#872724ClinicalTrials.gov
• Januvia Re-examination Study (MK-0431-181)#901506ClinicalTrials.gov
• MK0524 Asthma POC Study (0524-008)(COMPLETED)#1007261ClinicalTrials.gov
• GARDASIL™ Post Marketing Surveillance in the Philippines (V501-077)#1171514ClinicalTrials.gov
• Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)#1338484ClinicalTrials.gov
• A Single Dose Study of MK-8266 (MK-8266-001)#829404ClinicalTrials.gov
• Randomized Sitagliptin Withdrawal Study (MK-0431-845)#843384ClinicalTrials.gov
• Developing World Study for RotaTeq™ (V260-015)(COMPLETED)#849759ClinicalTrials.gov
• Zostavax® at Minimum Release Specification Approaching Expiry (V211-044)#859590ClinicalTrials.gov
• Treatment of Patients With Anxiety Disorder (0777-022)#860778ClinicalTrials.gov
• A Study of V132 in Healthy Older Participants (V132-001)#905330ClinicalTrials.gov
• Safety and Immunogenicity of V540B in Healthy Adults (V540B-002).#905762ClinicalTrials.gov
• Efficacy & Safety of SCH 900435 in Schizophrenia (Study P06079)(WITHDRAWN)#918919ClinicalTrials.gov
• MK0767 and Sulfonylurea Combination Study (0767-027)#978980ClinicalTrials.gov